Induction of osteogenic differentiation of MSCs by GSK3β knockdown through GSK3β siRNAs transfection

The development of effective strategies for the treatment of bone defects is based on gene therapy methods aimed at regulating the differentiation of osteoprogenitor cells. One approach is the development of knockdown systems of inhibitory genes of osteogenic cell differentiation using siRNA molecules. In this work, we developed approaches to induce osteogenic differentiation of mesenchymal stem cells (MSCs) by knockdown of GSK3β using siRNAs in cultures of MSCs derived from human adipose tissue (AD-MSCs). For this purpose, we performed a comparative evaluation of the efficacy of lipoplexes and polyplexes formed with one of the 4 siRNA molecules and 5 commercial transfection agents most commonly used in laboratory practice. The most effective transfection agent appeared to be PEI, which demonstrated high cytocompatibility in free form and as part of polyplexes even when maximum concentrations were used. Using the polyplexes formed by siRNA molecule designed for the first time and PEI, we developed a highly efficient GSK3β gene knockdown system, which showed its effectiveness in cultures of AD-MSCs. As a result, we demonstrated the osteoinductive properties of GSK3β siRNA molecules in these cultures. The results obtained can be applied in the development of gene therapy strategies based on siRNA molecules in human bone tissue diseases.

[1]  Xichao Wang,et al.  Delivering siRNA to control osteogenic differentiation and real-time detection of cell differentiation in human mesenchymal stem cells using multifunctional gold nanoparticles. , 2020, Journal of materials chemistry. B.

[2]  A. Dyakonov,et al.  Osteogenic Differentiation of Human Adipose Tissue-Derived MSCs by Non-Toxic Calcium Poly(ethylene phosphate)s , 2019, International journal of molecular sciences.

[3]  Yuanyu Huang,et al.  Clinical advances of siRNA therapeutics , 2019, The journal of gene medicine.

[4]  P. Saw,et al.  siRNA therapeutics: a clinical reality , 2019, Science China Life Sciences.

[5]  I. V. Chernikov,et al.  Current Development of siRNA Bioconjugates: From Research to the Clinic , 2019, Front. Pharmacol..

[6]  Andrew Hamann,et al.  Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications , 2019, Journal of biological engineering.

[7]  Yixiao Xing,et al.  Effect of 1α, 25-dihydroxyvitamin D3 on the osteogenic differentiation of human periodontal ligament stem cells and the underlying regulatory mechanism , 2018, International journal of molecular medicine.

[8]  Jonathan R. Peterson,et al.  TGF-β Family Signaling in Mesenchymal Differentiation. , 2018, Cold Spring Harbor perspectives in biology.

[9]  M. Dearnley,et al.  Polymers in the Delivery of siRNA for the Treatment of Virus Infections , 2017, Topics in Current Chemistry.

[10]  Piero Carninci,et al.  FANTOM5 transcriptome catalog of cellular states based on Semantic MediaWiki , 2016, Database J. Biol. Databases Curation.

[11]  Huifang Zhou,et al.  A regulatory loop containing miR-26a, GSK3β and C/EBPα regulates the osteogenesis of human adipose-derived mesenchymal stem cells , 2015, Scientific Reports.

[12]  G. Bedogni,et al.  Silencing efficacy prediction: a retrospective study on target mRNA features , 2015, Bioscience reports.

[13]  Wei Wang,et al.  Cationic nanocarriers induce cell necrosis through impairment of Na+/K+-ATPase and cause subsequent inflammatory response , 2015, Cell Research.

[14]  J. Woodgett,et al.  The GSK-3 family as therapeutic target for myocardial diseases. , 2015, Circulation research.

[15]  Alfredo Ferro,et al.  Computational Design of Artificial RNA Molecules for Gene Regulation , 2014, Methods in molecular biology.

[16]  B. Lanske,et al.  Indian Hedgehog Signaling Regulates Transcription and Expression of Collagen Type X via Runx2/Smads Interactions* , 2014, The Journal of Biological Chemistry.

[17]  Jing Hu,et al.  Regulation of Wnt/β-catenin signaling by posttranslational modifications , 2014, Cell & Bioscience.

[18]  P. Genever,et al.  Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitor. , 2014, Stem cell research.

[19]  A. James,et al.  Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation , 2013, Scientifica.

[20]  G. Lewis,et al.  Inhibition of GSK-3β Rescues the Impairments in Bone Formation and Mechanical Properties Associated with Fracture Healing in Osteoblast Selective Connexin 43 Deficient Mice , 2013, PloS one.

[21]  P. Hall,et al.  Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats. , 2013, Toxicology and applied pharmacology.

[22]  J. Handschel,et al.  Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro , 2013, Stem Cell Research & Therapy.

[23]  T. He,et al.  BMP signaling in mesenchymal stem cell differentiation and bone formation. , 2013, Journal of biomedical science and engineering.

[24]  F. Takahashi‐Yanaga,et al.  Activator or inhibitor? GSK-3 as a new drug target. , 2013, Biochemical pharmacology.

[25]  L. Andĕra,et al.  Inhibition of vacuolar ATPase attenuates the TRAIL‐induced activation of caspase‐8 and modulates the trafficking of TRAIL receptosomes , 2013, The FEBS journal.

[26]  S. Larsson,et al.  Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation. , 2013, Bone.

[27]  D. Benoit,et al.  Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA. , 2012, Biomacromolecules.

[28]  Y. Omidi,et al.  Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells. , 2011, BioImpacts : BI.

[29]  Daniel R. Caffrey,et al.  siRNA Off-Target Effects Can Be Reduced at Concentrations That Match Their Individual Potency , 2011, PloS one.

[30]  P. Croucher,et al.  Glycogen synthase kinase‐3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  S. Garg,et al.  Development of a software tool and criteria evaluation for efficient design of small interfering RNA. , 2011, Biochemical and biophysical research communications.

[32]  R. Mahato,et al.  Lipid and polymeric carrier-mediated nucleic acid delivery , 2010, Expert opinion on drug delivery.

[33]  F. Barry,et al.  Enhanced lipoplex‐mediated gene expression in mesenchymal stem cells using reiterated nuclear localization sequence peptides , 2010, The journal of gene medicine.

[34]  Shigeru Takasaki,et al.  Selecting effective siRNA target sequences by using Bayes' theorem , 2009, Comput. Biol. Chem..

[35]  ANSI/AAMI/ISO 10993-5:2009/(R)2014; Biological evaluation of medical devices —Part 5: Tests for in vitro cytotoxicity , 2009 .

[36]  A. Mikaelyan,et al.  Molecular and genetic regulation of osteogenic differentiation of mesenchymal stromal cells , 2008, Biology Bulletin.

[37]  E. Robertis,et al.  Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal , 2007, Cell.

[38]  Kozo Nakamura,et al.  GSK-3β Controls Osteogenesis through Regulating Runx2 Activity , 2007, PloS one.

[39]  Masaki Noda,et al.  Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. , 2007, Molecular biology of the cell.

[40]  D. Chuang,et al.  Regulation and Function of Glycogen Synthase Kinase-3 Isoforms in Neuronal Survival* , 2006, Journal of Biological Chemistry.

[41]  Jean-Philippe Vert,et al.  An accurate and interpretable model for siRNA efficacy prediction , 2006, BMC Bioinformatics.

[42]  D. Chuang,et al.  Differential Roles of Glycogen Synthase Kinase-3 Isoforms in the Regulation of Transcriptional Activation* , 2006, Journal of Biological Chemistry.

[43]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Xin Zheng,et al.  BIOINFORMATICSAPPLICATIONS NOTE doi:10.1093/bioinformatics/btl026 Databases and ontologies , 2005 .

[45]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[46]  Szymon M. Kielbasa,et al.  HuSiDa—the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells , 2004, Nucleic Acids Res..

[47]  P. Opolon,et al.  Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. , 2002, Biochemical and biophysical research communications.

[48]  A. Mikos,et al.  Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. , 2001, Biomaterials.

[49]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[50]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[51]  Jason A. Burdick,et al.  Engineered Hydrogels for Local and Sustained Delivery of RNA‐Interference Therapies , 2017, Advanced healthcare materials.

[52]  Murali Ramamoorth,et al.  Non viral vectors in gene therapy- an overview. , 2015, Journal of clinical and diagnostic research : JCDR.

[53]  Jan Gorodkin,et al.  RNA Sequence, Structure, and Function: Computational and Bioinformatic Methods , 2014, Methods in Molecular Biology.

[54]  Hakim Tafer,et al.  Bioinformatics of siRNA design. , 2014, Methods in molecular biology.

[55]  Shigeru Takasaki,et al.  Methods for selecting effective siRNA target sequences using a variety of statistical and analytical techniques. , 2013, Methods in molecular biology.

[56]  Yin Qin-wei.  siRNA-MEDIATED GENE SILENCING , 2004 .

[57]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. , 1980, European journal of biochemistry.